These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 7586622

  • 1. High prevalence and little change in TSH receptor blocking antibody titres with thyroxine and antithyroid drug therapy in patients with non-goitrous autoimmune thyroiditis.
    Cho BY, Kim WB, Chung JH, Yi KH, Shong YK, Lee HK, Koh CS.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):465-71. PubMed ID: 7586622
    [Abstract] [Full Text] [Related]

  • 2. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy.
    Khoo DH, Eng PH, Ho SC, Fok AC.
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):73-9. PubMed ID: 10468968
    [Abstract] [Full Text] [Related]

  • 3. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 4. Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins.
    Sato K, Okamura K, Yoshinari M, Ikenoue H, Kuroda T, Torisu M, Fujishima M.
    J Clin Endocrinol Metab; 1990 Oct; 71(4):855-60. PubMed ID: 1976127
    [Abstract] [Full Text] [Related]

  • 5. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis.
    Rieu M, Richard A, Rosilio M, Laplanche S, Ropion V, Fombeur JP, Berrod JL.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):529-35. PubMed ID: 8187321
    [Abstract] [Full Text] [Related]

  • 6. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
    Tamaki H, Amino N, Aozasa M, Mori M, Iwatani Y, Tachi J, Nose O, Tanizawa O, Miyai K.
    Am J Perinatol; 1989 Jul; 6(3):296-303. PubMed ID: 2567172
    [Abstract] [Full Text] [Related]

  • 7. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan.
    Tamaki H, Amino N, Kimura M, Hidaka Y, Takeoka K, Miyai K.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1382-6. PubMed ID: 1977757
    [Abstract] [Full Text] [Related]

  • 8. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK, Sohn I.
    Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
    [Abstract] [Full Text] [Related]

  • 9. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.
    Takasu N, Yamada T, Katakura M, Yamauchi K, Shimizu Y, Ishizuki Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935
    [Abstract] [Full Text] [Related]

  • 10. Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease.
    Tada H, Mizuta I, Takano T, Tatsumi KI, Izumi Y, Hidaka Y, Amino N.
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):403-8. PubMed ID: 12641621
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
    Zhu Y, Portmann L, Dénéréaz N, Lemarchand-Béraud T.
    Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
    [Abstract] [Full Text] [Related]

  • 12. Comparison of atrophic and goitrous auto-immune thyroiditis in children: clinical, laboratory and TSH-receptor antibody studies.
    Matsuura N, Konishi J, Yuri K, Harada S, Fujieda K, Nohara Y, Mikami Y, Kasagi K, Iida Y, Hosoda A.
    Eur J Pediatr; 1990 May; 149(8):529-33. PubMed ID: 2347350
    [Abstract] [Full Text] [Related]

  • 13. A strong association between thyrotropin receptor-blocking antibody-positive atrophic autoimmune thyroiditis and HLA-DR8 and HLA-DQB1*0302 in Koreans.
    Cho BY, Chung JH, Shong YK, Chang YB, Han H, Lee JB, Lee HK, Koh CS.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):611-5. PubMed ID: 8103769
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
    Cho BY, Shong MH, Yi KH, Lee HK, Koh CS, Min HK.
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
    [Abstract] [Full Text] [Related]

  • 15. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs.
    Kawai K, Tamai H, Matsubayashi S, Mukuta T, Morita T, Kubo C, Kuma K.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):551-6. PubMed ID: 8548939
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis.
    Tokuda Y, Kasagi K, Iida Y, Hatabu H, Misaki T, Arai K, Endo K, Konishi J.
    J Clin Endocrinol Metab; 1988 Aug; 67(2):251-8. PubMed ID: 2899088
    [Abstract] [Full Text] [Related]

  • 17. [Significance of circulating anti-thyroid stimulating hormone (TSH) receptor antibodies in patients with autoimmune thyroid diseases--thyroid stimulation blocking antibody in patients with Graves' disease].
    Fujihira T.
    J UOEH; 1989 Dec 01; 11(4):393-401. PubMed ID: 2575267
    [Abstract] [Full Text] [Related]

  • 18. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
    Watanabe Y, Tahara K, Hirai A, Tada H, Kohn LD, Amino N.
    Thyroid; 1997 Feb 01; 7(1):13-9. PubMed ID: 9086564
    [Abstract] [Full Text] [Related]

  • 19. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T.
    N Engl J Med; 1991 Apr 04; 324(14):947-53. PubMed ID: 1900575
    [Abstract] [Full Text] [Related]

  • 20. Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto's thyroiditis.
    Hegedüs L, Hansen JM, Feldt-Rasmussen U, Hansen BM, Høier-Madsen M.
    Clin Endocrinol (Oxf); 1991 Sep 04; 35(3):235-8. PubMed ID: 1742880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.